A pilot study of intravitreal injection of methotrexate for intraocular lymphoma
Not Applicable
- Conditions
- Intraocular lymphoma
- Registration Number
- JPRN-UMIN000021943
- Lead Sponsor
- Department of Ophthalmology & Visual Science, Tokyo Medical and Dental University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Eyes with severe intraocular infectious disease (2) History of serious adverse reactions by methotrexate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Remission of the intraocular lesions, visual acuity, cytokine levels in intraocular fluids, and recurrence rate in two years.
- Secondary Outcome Measures
Name Time Method Rate of adverse events, and relapse rate (central nerve system and other lesion)